| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |